Your source for the latest medtech news from AdvaMed® and our members.
WASHINGTON, D.C. – AdvaMed®, the world’s largest trade organization representing medical technology companies, released the following statement from President and CEO Scott Whitaker on President Biden’s nomination of Chiquita Brooks-LaSure to…
AdvaMed® announced this week it has entered into a formal relationship, through a memorandum of understanding (MOU), with MECOMED, the medical devices, imaging, and diagnostics trade association in the Middle…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®)—the world’s largest trade association for medical technology and diagnostics companies in the world—released the following statement from President and CEO Scott Whitaker on…
AdvaMed® unveiled a newly repurposed platform to help device manufacturers locate and partner with thousands of component part manufacturers and sellers, should they need them during the COVID pandemic.
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 206-225-5226
AdvaMed® commended the Honorable Finance Minister and the Government of India for moving to increase the health sector budget to 2,23,846 crore, a 137% increase over the previous year.
AdvaMed® President and CEO Scott Whitaker released a statement on the announcement by the European Union that COVID-19 vaccines covered by an Advanced Purchase Agreement (APA) require in many instances…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from Pat Fogarty, Vice President, Assistant General Counsel, and Director, Civil Justice Policy regarding yesterday’s oral arguments…
WASHINGTON, D.C. – Today AdvaMed® President and CEO Scott Whitaker sent a letter to President Biden affirming the industry’s support of the administration’s national COVID-19 strategy and sharing the industry’s perspective on…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
WASHINGTON, D.C. – Today AdvaMed® President and CEO Scott Whitaker released the following statement: